214 related articles for article (PubMed ID: 8080996)
1. A novel membrane antigen selectively expressed on terminally differentiated human B cells.
Goto T; Kennel SJ; Abe M; Takishita M; Kosaka M; Solomon A; Saito S
Blood; 1994 Sep; 84(6):1922-30. PubMed ID: 8080996
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24.
Ozaki S; Kosaka M; Wakatsuki S; Abe M; Koishihara Y; Matsumoto T
Blood; 1997 Oct; 90(8):3179-86. PubMed ID: 9376601
[TBL] [Abstract][Full Text] [Related]
3. Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells.
Ozaki S; Kosaka M; Wakahara Y; Ozaki Y; Tsuchiya M; Koishihara Y; Goto T; Matsumoto T
Blood; 1999 Jun; 93(11):3922-30. PubMed ID: 10339501
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells.
Tong AW; Lee JC; Stone MJ
Blood; 1987 Jan; 69(1):238-45. PubMed ID: 3098320
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
[TBL] [Abstract][Full Text] [Related]
7. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
Jensen GS; Mant MJ; Pilarski LM
Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24.
Ozaki S; Kosaka M; Harada M; Nishitani H; Odomi M; Matsumoto T
Cancer; 1998 Jun; 82(11):2184-90. PubMed ID: 9610698
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro.
Tong AW; Zhang BQ; Mues G; Solano M; Hanson T; Stone MJ
Blood; 1994 Nov; 84(9):3026-33. PubMed ID: 7524765
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
Uckun FM; Chelstrom LM; Irvin JD; Finnegan D; Gunther R; Young J; Kuebelbeck V; Myers DE; Houston LL
Blood; 1992 May; 79(10):2649-61. PubMed ID: 1375109
[TBL] [Abstract][Full Text] [Related]
11. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
[TBL] [Abstract][Full Text] [Related]
12. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
13. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.
Ohtomo T; Sugamata Y; Ozaki Y; Ono K; Yoshimura Y; Kawai S; Koishihara Y; Ozaki S; Kosaka M; Hirano T; Tsuchiya M
Biochem Biophys Res Commun; 1999 May; 258(3):583-91. PubMed ID: 10329429
[TBL] [Abstract][Full Text] [Related]
15. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic stimulation of malignant B cells Waldenstrøm's macroglobulinaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.
Bloem AC; Chand MA; van Camp B; Bast EJ; Ballieux RE
Clin Exp Immunol; 1986 Jan; 63(1):156-62. PubMed ID: 3082547
[TBL] [Abstract][Full Text] [Related]
17. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
18. Two monoclonal antibodies (OKIa1 and OKT10) for the study of the final B cell maturation.
Van Camp B; Thielemans C; Dehou MF; De Mey J; De Waele M
J Clin Immunol; 1982 Jul; 2(3 Suppl):67S-74S. PubMed ID: 6813349
[TBL] [Abstract][Full Text] [Related]
19. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.
Zola H; McNamara PJ; Moore HA; Smart IJ; Brooks DA; Beckman IG; Bradley J
Clin Exp Immunol; 1983 Jun; 52(3):655-64. PubMed ID: 6191892
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody defining human B cell differentiation antigen (HLB-1 antigen).
Kasai K; Koshiba H; Ishii Y; Kikuchi K
Microbiol Immunol; 1983; 27(1):51-64. PubMed ID: 6408355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
